The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Nanoparticles and microparticles as vaccine-delivery systems
Abstract
Vaccine-delivery systems are generally particulate (e.g., emulsions, microparticles and liposomes) and have comparable dimensions to the pathogens, which the immune system evolved to combat. Increasingly more sophisticated delivery systems are being developed in which immunostimulatory adjuvants may be incorporated with the antigen. The rationale for this approach is to ensure that both the antigen and adjuvant are delivered into the same population of antigen-presenting cells. Enhancement of adjuvant activity through the use of micro- and nanoparticulate delivery systems is particularly exciting, as synergistic effects are often seen resulting in immune responses stronger than those elicited by the adjuvant or delivery system alone. Micro- and nanoparticles also offer the possibility of enhancement of their uptake by appropriate cells through manipulation of their surface properties. The next important step in the development of many of the experimental microparticle- and nanoparticle-based technologies will be evaluation of effectiveness in human trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,719
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Roy, K., Mao, H.-Q., Huang, S. K., & Leong, K. W. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,106
Aluminum compounds as vaccine adjuvants
Gupta, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00008-8 · Cited by 623
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 499
Zinkernagel, R. M., Ehl, S., Aichele, P., Oehen, S., Kündig, T., & Hengartner, H. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00969.x · Cited by 489
Cationic microparticles: A potent delivery system for DNA vaccines
Singh, M., Briones, M., Ott, G., & O'Hagan, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.811 · Cited by 489
Self-citationAluminium compounds for use in vaccines
Lindblad, E. B. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01286.x · Cited by 488
Niwa, T., Takeuchi, H., Hino, T., Kunou, N., & Kawashima, Y. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90097-o · Cited by 483
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Improving protein therapeutics with sustained-release formulations
Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 460
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449
Biodegradable Microspheres in Drug Delivery
Okada, H., & Toguchi, H. (1995) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v12.i1.10 · Cited by 397
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., & Gilley, R. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2978-2986.1991 · Cited by 368
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
TAMBER, H., JOHANSEN, P., MERKLE, H., & GANDER, B. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.002 · Cited by 316
A month–long effect from a single injection of microencapsulated human growth hormone
Johnson, O. L., Cleland, J. L., Lee, H. J., Charnis, M., Duenas, E., Jaworowicz, W., Shepard, D., Shahzamani, A., Jones, A. J. S., & Putney, S. D. (1996) · Nature Medicine · doi:10.1038/nm0796-795 · Cited by 292
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
Thiele, L., Rothen-Rutishauser, B., Jilek, S., Wunderli-Allenspach, H., Merkle, H. P., & Walter, E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00412-6 · Cited by 281
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles
Konan, Y. N., Gurny, R., & Allémann, E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00944-9 · Cited by 279
Phagocytosis of polymer microspheres by macrophages
Tabata, Y., & Ikada, Y. (2006) · Advances in Polymer Science · doi:10.1007/bfb0043062 · Cited by 270
Biodegradable microparticles as controlled release antigen delivery systems.
O’Hagan, D. T., Rahman, D., McGee, J. P., Jeffery, H., Davies, M. C., Williams, P. M., Davis, S. S., & Challacombe, S. (1991) · PubMed Central · Cited by 270
Self-citationDevelopment and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
Blanco, M. D., & Alonso, M. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00056-8 · Cited by 269
Seeking wisdom in innate immunity
Fearon, D. T. (1997) · Nature · doi:10.1038/40967 · Cited by 267
Cleland, J. L., & Jones, A. J. S. (1996) · Pharmaceutical Research · doi:10.1023/a:1016063109373 · Cited by 266
Yip, H. C., Karulin, A. Y., Tary-Lehmann, M., Hesse, M. D., Radeke, H., Heeger, P. S., Trezza, R. P., Heinzel, F. P., Forsthuber, T., & Lehmann, P. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3942 · Cited by 258
pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery
Bisht, S., Bhakta, G., Mitra, S., & Maitra, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.035 · Cited by 253
Elamanchili, P., Diwan, M., Cao, M., & Samuel, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.032 · Cited by 246
O'Hagan, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00012-x · Cited by 243
Self-citationTabata, Y., & Ikada, Y. (1988) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820221002 · Cited by 235
Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Colloid & Polymer Science · doi:10.1007/s003960050050 · Cited by 227
A Compendium of Vaccine Adjuvants and Excipients
Vogel, F. R., & Powell, M. F. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_7 · Cited by 217
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
Self-citationScholes, P. D., Coombes, A. G. A., Illum, L., Daviz, S. S., Vert, M., & Davies, M. C. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90103-c · Cited by 208
Bivas-Benita, M., van Meijgaarden, K. E., Franken, K. L. M. C., Junginger, H. E., Borchard, G., Ottenhoff, T. H. M., & Geluk, A. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.09.044 · Cited by 195
A single-step immunization by sustained antigen release
Preis, I., & Langer, R. S. (1979) · Journal of Immunological Methods · doi:10.1016/0022-1759(79)90341-7 · Cited by 193
TABATA, Y. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00149-1 · Cited by 181
Oral particulate delivery: status and future trends
Chen, H. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00047-7 · Cited by 181
Jung, T., Kamm, W., Breitenbach, A., Hungerer, K.-D., Hundt, E., & Kissel, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011063232257 · Cited by 177
Diwan, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00275-4 · Cited by 177
O'Hagan, D. T., Jeffery, H., & Davis, S. S. (1993) · Vaccine · doi:10.1016/0264-410x(93)90387-d · Cited by 175
Self-citationMicroparticle-based technologies for vaccines
O’Hagan, D. T., Singh, M., & Ulmer, J. B. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.017 · Cited by 172
Self-citationPoly-l-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy
Minigo, G., Scholzen, A., Tang, C. K., Hanley, J. C., Kalkanidis, M., Pietersz, G. A., Apostolopoulos, V., & Plebanski, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.086 · Cited by 158
Segal, B. M., Chang, J. T., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5683 · Cited by 153
Molpeceres, J., Guzmán, M., Aberturas, M. R., Chacon, M., & Berges, L. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950164r · Cited by 151
Controlled release microparticles for vaccine development
O’Hagan, D. T., Jeffery, H., Roberts, M. J. J., McGee, J. P., & Davis, S. S. (1991) · Vaccine · doi:10.1016/0264-410x(91)90295-h · Cited by 149
Self-citationImmunostimulatory CpG-Oligodeoxynucleotides Cause Extramedullary Murine Hemopoiesis
Sparwasser, T. D., Hültner, L., Koch, E. S., Luz, A., Lipford, G. B., & Wagner, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2368 · Cited by 147
Lipford, G. B., Sparwasser, T. D., Zimmermann, S., Heeg, K. M., & Wagner, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1228 · Cited by 138
Nagamoto, T., Hattori, Y., Takayama, K., & Maitani, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022414.17183.58 · Cited by 136
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity
Nixon, D. F., Hioe, C. E., Chen, P., Bian, Z., Kuebler, P., Li, M.-L., Qiu, H., Li, X.-M., Singh, M., Richardson, J. L., et al. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00099-0 · Cited by 133
Self-citationKazzaz, J., Neidleman, J. A., Singh, M., Ott, G. S., & O’Hagan, D. T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00226-1 · Cited by 127
Self-citationNovel Polysaccharide-Decorated Poly(Isobutyl Cyanoacrylate) Nanoparticles
Chauvierre, C., Labarre, D., Couvreur, P., & Vauthier, C. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003376.57954.2a · Cited by 124
Jung, T., Breitenbach, A., & Kissel, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00201-7 · Cited by 120
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
Thomasin, C., Nam‐Trân, H., Merkle, H. P., & Gander, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970047r · Cited by 118
Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Diwan, M., Elamanchili, P., Cao, M., & Samuel, J. (2004) · Current Drug Delivery · doi:10.2174/1567201043334597 · Cited by 118
Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.
Schwendeman, S. P., Costantino, H. R., Rk, G., Siber, G. R., Klibanov, A. M., & Langer, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11234 · Cited by 116
Cationic Microparticles Are an Effective Delivery System for Immune Stimulatory CpG DNA
Singh, M., Ott, G. S., Kazzaz, J., Ugozzoli, M., Briones, M., Donnelly, J., & O’Hagan, D. T. (2001) · Pharmaceutical Research · doi:10.1023/a:1012269226066 · Cited by 115
Self-citationPEG-PLA Nanoparticles as Carriers for Nasal Vaccine Delivery
Vila, A., Sánchez, A., Évora, C., Soriano, I., Jato, J. L. V., & Alonso, M. J. (2004) · Journal of Aerosol Medicine · doi:10.1089/0894268041457183 · Cited by 115
Murakami, H., Kobayashi, M., Takeuchi, H., & Kawashimà, Y. (2000) · Powder Technology · doi:10.1016/s0032-5910(99)00182-5 · Cited by 113
Relyveld, E. H., Bizzini, B., & Gupta, R. K. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00288-0 · Cited by 113
Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L., Spérandio, S., Melber, K., Janowicz, Z. A., Betbeder, D., & Moynier, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00191-3 · Cited by 108
Microparticles and Nanoparticles as Delivery Systems for DNA Vaccines
Cui, Z., & Mumper, R. J. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.10 · Cited by 105
Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles
Arbós, P., Arangoa, M. A., Campanero, M. A., & Irache, J. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00182-5 · Cited by 102
A Practical Approach to the use of Nanoparticles for Vaccine Delivery
Wendorf, J. R., Singh, M., Chesko, J., Kazzaz, J., Soewanan, E., Ugozzoli, M., & O’Hagan, D. T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20728 · Cited by 100
Self-citationShi, L., Caulfield, M. J., Chern, R. T., Wilson, R. A., Sanyal, G., & Volkin, D. B. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10042 · Cited by 96
Singh, M., Ugozzoli, M., Kazzaz, J., Chesko, J., Soenawan, E., Mannucci, D., Titta, F., Contorni, M., Volpini, G., & Guidice, G. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.046 · Cited by 92
Self-citationSingh, M., Li, X.-M., McGee, J. P., et al. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00225-9 · Cited by 89
Self-citationChallenges facing adjuvants for cancer immunotherapy
Mesa, C., & Fernandez, L. E. (2004) · Immunology and Cell Biology · doi:10.1111/j.0818-9641.2004.01279.x · Cited by 86
Peltonen, L., Koistinen, P., Karjalainen, M., Häkkinen, A., & Hirvonen, J. J. (2002) · AAPS PharmSciTech · doi:10.1208/pt030432 · Cited by 83
Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres
Tabata, Y., & Ikada, Y. (1987) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1987.tb06972.x · Cited by 79
Implication of nanoparticles/microparticles in mucosal vaccine delivery
Vyas, S. P., & Gupta, P. N. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.401 · Cited by 78
Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against Squalene
Giudice, G. D., Fragapane, E., Bugarini, R., Hora, M., Henriksson, T., Palla, E., O’Hagan, D. T., Donnelly, J., Rappuoli, R., & Podda, A. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00191-06 · Cited by 78
Self-citationBriones, M., Singh, M., Ugozzoli, M., Kazzaz, J., Klakamp, S. L., Ott, G. S., & O’Hagan, D. T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011053931523 · Cited by 73
Self-citationThomasin, C., Merkle, H. P., & Gander, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970048j · Cited by 72
Singh, M., Kazzaz, J., Chesko, J., Soenawan, E., Ugozzoli, M., Giuliani, M. M., Pizza, M., Rappouli, R., & O’Hagan, D. T. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10538 · Cited by 72
Self-citationOtten, G. R., Schaefer, M. E., Doe, B., Liu, H., Srivastava, I. K., Megede, J. Z., Kazzaz, J., Lian, Y., Singh, M., Ugozzoli, M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8189-8200.2005 · Cited by 72
Self-citationPoly (butyl-2-cyanoacrylate) particles as adjuvants for oral immunization
O’Hagan, D. T., Palin, K. J., & Davis, S. S. (1989) · Vaccine · doi:10.1016/0264-410x(89)90231-4 · Cited by 71
Self-citationWehrlé, P., Magenheim, B., & Benita, S. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 69
Influence of sterilization processes on poly(ε-caprolactone) nanospheres
Masson, V., Maurin, F., Fessi, H., & Devissaguet, J. P. (1997) · Biomaterials · doi:10.1016/s0142-9612(96)00144-5 · Cited by 65
Microparticle vaccine approaches to stimulate mucosal immunisation
Brayden, D. J., & Baird, A. W. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01445-9 · Cited by 64
Nanoparticles as Adjuvants for Vaccines
Kreuter, J. (1995) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-1823-5_19 · Cited by 58
Development of a Novel Vaccine Delivery System Based on Gantrez Nanoparticles
Gómez, S., Gamazo, C., Román, B. S., et al. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.471 · Cited by 45
Ambiguities in the preclinical quality assessment of microparticulate vaccines
Johansen, P., Gander, B., Merkle, H. P., & Sesardic, D. (2000) · Trends in biotechnology · doi:10.1016/s0167-7799(00)01437-2 · Cited by 43
Katare, Y. K., Panda, A. K., Lalwani, K., Haque, I. U., & Ali, M. M. (2003) · Drug Delivery · doi:10.1080/drd_10_4_231 · Cited by 40
Size effect on the antibody production induced by biodegradable microspheres containing antigen
Nakaoka, R., Inoue, Y., Tabata, Y., & Ikada, Y. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00016-3 · Cited by 39
Pandit, S., Cevher, E., Zariwala, M. G., Somavarapu, S., & Alpar, H. O. (2007) · Journal of Microencapsulation · doi:10.1080/02652040701443700 · Cited by 35
Puri, N., Kou, J. H., & Sinko, P. J. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00289-3 · Cited by 30
Sasiak, A. B., Bolgiano, B., Crane, D. T., Hockley, D. J., Corbel, M. J., & Sesardic, D. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00266-8 · Cited by 28
Cited by
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract
Powell, J. J., Faria, N., Thomas-McKay, E., & Pele, L. C. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.006 · Cited by 543
Metadata
- Authors
- Singh, M., Chakrapani, A., & O’Hagan, D.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2007-10-01
- Volume
- 6
- Issue
- 5
- Pages
- 797-808
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2140138078
- Cited by
- 259
- References
- 93
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.